Recent News

• 06.12.2025 - Quince Therapeutics Announces Pricing of Up to $22 Million Private Placement of Securities
• 06.12.2025 - Quince Therapeutics Announces Pricing of Up to $22 Million Private Placement of Securities
• 06.04.2025 - 2025 Annual Meeting of Stockholders
• 06.04.2025 - 2025 Annual Meeting of Stockholders
• 06.03.2025 - Quince Therapeutics Exceeds 75% Enrollment in Pivotal Phase 3 NEAT Clinical Trial in Ataxia-Telangiectasia
• 06.03.2025 - Quince Therapeutics Exceeds 75% Enrollment in Pivotal Phase 3 NEAT Clinical Trial in Ataxia-Telangiectasia
• 05.13.2025 - Quince Therapeutics Provides Business Update and Reports First Quarter 2025 Financial Results
• 05.13.2025 - Quince Therapeutics Provides Business Update and Reports First Quarter 2025 Financial Results
• 05.07.2025 - Citizens Life Sciences Conference

Recent Filings

• 06.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.05.2025 - 8-K Current report
• 05.13.2025 - 8-K Current report
• 05.13.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]